PURPOSE: The genus Arcobacter includes bacteria that are considered emergent pathogens because they can produce infections in humans and animals. The most common symptoms are bloody and non-bloody persistent diarrhea but cases with abdominal cramps without diarrhea or asymptomatic cases have also been described as well as cases with bacteremia. The objective was to characterize Arcobacter clinical strains isolated from the faeces of patients from three Spanish hospitals. METHODOLOGY: We have characterized 28 clinical strains (27 of A. butzleri and one of A. cryaerophilus) isolated from faeces, analysing their epidemiological relationship using the multilocus sequence typing (MLST) approach and screening them for their antibiotic susceptibility and for the presence of virulence genes.Results/Key findings. Typing results showed that only one of the 28 identified sequence types (i.e. ST 2) was already present in the MLST database. The other 27 STs constituted new records because they included new alleles for five of the seven genes or new combinations of known alleles of the seven genes. All strains were positive for the ciaB virulence gene and sensitive to tetracycline. However, 7.4 % of the A. butzleri and A. cryaerophilus strains showed resistance to ciprofloxacin. CONCLUSION: The fact that epidemiological unrelated strains show the same ST indicates that other techniques with higher resolution should be developed to effectively recognize the infection source. Resistance to ciprofloxacin, one of the antibiotics recommended for the treatment of Arcobacter intestinal infections, demonstrated in 10.7 % of the strains, indicates the importance of selecting the most appropriate effective treatment.
PURPOSE: The genus Arcobacter includes bacteria that are considered emergent pathogens because they can produce infections in humans and animals. The most common symptoms are bloody and non-bloody persistent diarrhea but cases with abdominal cramps without diarrhea or asymptomatic cases have also been described as well as cases with bacteremia. The objective was to characterize Arcobacter clinical strains isolated from the faeces of patients from three Spanish hospitals. METHODOLOGY: We have characterized 28 clinical strains (27 of A. butzleri and one of A. cryaerophilus) isolated from faeces, analysing their epidemiological relationship using the multilocus sequence typing (MLST) approach and screening them for their antibiotic susceptibility and for the presence of virulence genes.Results/Key findings. Typing results showed that only one of the 28 identified sequence types (i.e. ST 2) was already present in the MLST database. The other 27 STs constituted new records because they included new alleles for five of the seven genes or new combinations of known alleles of the seven genes. All strains were positive for the ciaB virulence gene and sensitive to tetracycline. However, 7.4 % of the A. butzleri and A. cryaerophilus strains showed resistance to ciprofloxacin. CONCLUSION: The fact that epidemiological unrelated strains show the same ST indicates that other techniques with higher resolution should be developed to effectively recognize the infection source. Resistance to ciprofloxacin, one of the antibiotics recommended for the treatment of Arcobacter intestinal infections, demonstrated in 10.7 % of the strains, indicates the importance of selecting the most appropriate effective treatment.
Authors: Marta Caruso; Laura Latorre; Gianfranco Santagada; Rosa Fraccalvieri; Laura Maria Difato; Angela Miccolupo; Loredana Capozzi; Elisabetta Bonerba; Anna Mottola; Antonio Parisi Journal: Ital J Food Saf Date: 2019-02-08
Authors: Markus M Heimesaat; Greta Gölz; Vanessa Brückner; Ulrike Fiebiger; Ralf Ignatius; Johannes Friesen; Martin Eisenblätter; Marlies Höck; Thomas Alter; Stefan Bereswill Journal: Gut Pathog Date: 2020-01-08 Impact factor: 4.181
Authors: Paksathorn Kietsiri; Chonchanok Muangnapoh; Woradee Lurchachaiwong; Paphavee Lertsethtakarn; Ladaporn Bodhidatta; Orasa Suthienkul; Norman C Waters; Samandra T Demons; Brian A Vesely Journal: PLoS One Date: 2021-02-05 Impact factor: 3.240
Authors: Ingrid Hänel; Eva Müller; Belén González Santamarina; Herbert Tomaso; Helmut Hotzel; Anne Busch Journal: Front Cell Infect Microbiol Date: 2021-03-17 Impact factor: 5.293
Authors: G Jiménez-Guerra; I Casanovas MorenoTorres; T D Moldovan; J M Navarro-Marí; J Gutiérrez-Fernández Journal: Rev Esp Quimioter Date: 2020-01-02 Impact factor: 1.553